$FLNA 8-K SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Other Events On October 16, 2026, the United States Court of Appeals for the Fifth Circuit (the “Fifth Circuit”) vacated the order of the U.S. District Court for the Western District of Texas (the “Texas District Court”) granting class certification ...
22 Sep 2026	8-K: Regulation FD Disclosure; Other Events AUSTIN, Texas, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing simufilam for the treatment of Tuberous Sclerosis C...
18 Sep 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
29 Jul 2026	8-K: Results of Operations and Financial Condition
15 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
28 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Mar 2026	8-K: Results of Operations and Financial Condition
10 Mar 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure
19 Feb 2026	8-K: Regulation FD Disclosure; Other Events
23 Dec 2025	8-K: Entry into a Material Definitive Agreement
18 Dec 2025	8-K: Other Events
17 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
03 Dec 2025	8-K: Other Events
12 Nov 2025	8-K: Results of Operations and Financial Condition
24 Oct 2025	8-K: Other Events
22 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
08 Sep 2025	8-K: Regulation FD Disclosure
14 Aug 2025	8-K: Results of Operations and Financial Condition
04 Aug 2025	8-K: Regulation FD Disclosure; Other Events

Comments